Stocks and Investing
Stocks and Investing
Tue, May 2, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Mon, May 1, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Carter Gould Maintained (AMGN) at Sell with Decreased Target to $225 on, May 1st, 2023
Carter Gould of Barclays, Maintained "Amgen Inc." (AMGN) at Sell with Decreased Target from $227 to $225 on, May 1st, 2023.
Carter has made no other calls on AMGN in the last 4 months.
There are 9 other peers that have a rating on AMGN. Out of the 9 peers that are also analyzing AMGN, 4 agree with Carter's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Robyn Karnauskas of "Truist Securities" Maintained at Hold with Decreased Target to $260 on, Monday, February 13th, 2023
- David Risinger of "SVB Leerink" Maintained at Hold with Decreased Target to $267 on, Thursday, February 2nd, 2023
- Evan David Seigerman of "BMO Capital" Maintained at Hold with Decreased Target to $253 on, Wednesday, February 1st, 2023
- Gregory Renza of "RBC Capital" Maintained at Hold with Decreased Target to $258 on, Wednesday, February 1st, 2023
These are the ratings of the 5 analyists that currently disagree with Carter
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $288 on, Friday, April 28th, 2023
- Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $290 on, Monday, April 24th, 2023
- Mohit Bansal of "Wells Fargo" Upgraded from Hold to Buy and Decreased Target to $265 on, Monday, March 13th, 2023
- Trung Huynh of "Credit Suisse" Maintained at Sell with Decreased Target to $220 on, Wednesday, February 1st, 2023
- Yaron Weber of "Cowen & Co." Maintained at Buy with Decreased Target to $289 on, Wednesday, February 1st, 2023
Contributing Sources